Eboo Pharmaceuticals Inc

eboo pharmaceuticals inc. (epi) is an emerging development-stage company building on over 20 years of chemistry and pharmacology r&d that originated in the burroughs wellcome laboratories of north carolina. epi is currently seeking funding and partnering opportunities to advance pre-clinical lead candidates through non-clinical, gold-standard, proof-of-concept studies and to drive viable candidates through ind-enabling programs and into early clinical studies. the company has access to over 750 compounds in the library of delta opioid agonists that have a variety of therapeutic targets. the most advanced current lead compounds are being developed for the treatment of parkinson’s disease, depression and protection of cardiac tissue from reperfusion injury (cardioprotection) following myocardial ischemia. additional areas with substantial research basis and ongoing lead selection include sexual dysfunction and wider areas of concern related to reperfusion injury.